Search
for
Sort by
Research 181–210 of 1000+
- Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata
- Hair today, gone tomorrow
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- A case of refractory alopecia areata successfully treated by combining delgocitinib ointment with excimer laser
- Novel potential therapeutic targets of alopecia areata
- Vitiligo—Current Treatment Options and Future Perspectives
- 470 Exploring the possible involvement of skin-resident memory T cells in refractory chronic alopecia areata
- Resident Memory T Cells in Autoimmune Skin Diseases
- Alopecia Areata: An Update on Treatment Options for Children
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Follicular Vitiligo: A Rare and Under Recognized Variant
- A Case Study on Exploring Immune Dysregulation in Alopecia Areata - Mechanisms and Treatments Outcomes
- Drug news and therapeutic news
- Common Causes of Hair Loss
- Registrars and Fellows Update Session 2
- Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Tofacitinib in the Management of Alopecia Universalis
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- JAK inhibitors and alopecia areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study